...
首页> 外文期刊>Cardiology >The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents.
【24h】

The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents.

机译:高细胞外钾对抗心律不齐药物抑制IKr的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Hyperkalemia is a potentially life-threatening disorder frequently occurring in hospitalized patients. The ischemic myocardium releases potassium into the extracellular space which can cause regional hyperkalemia. These changes may modify the effects of anti-arrhythmic drugs acting on the rapid component of the delayed rectifier potassium current (IKr). We evaluated the influence of increased extracellular potassium concentration [K(+)](e) on IKr inhibition by amiodarone, azimilide, dofetilide, quinidine and sotalol. METHODS AND RESULTS: Experiments were performed at room temperature. IKr current was studied by using HERG gene expressed in Xenopus oocytes as a model of cardiac IKr. Two-electrode voltage clamp technique was employed. The recording bath solutions contained either 5 or 10 mmol/l KCl. Amiodarone, azimilide, dofetilide, quinidine and sotalol all produced a dose-dependent inhibition of HERG current. At 5 mmol/l [K(+)](e), the IC(50) was 37.0 +/- 12.5 microM for amiodarone, 5.8 +/- 0.4 microM for azimilide, 1.5 +/- 0. 2 microM for dofetilide, 9.1 +/- 1.5 microM for quinidine, and 5.1 +/- 0.8 mM for sotalol. Raising the extracellular potassium to 10 mmol/l, HERG block by azimilide, dofetilide, quinidine and sotalol was significantly decreased, while the block by amiodarone was unchanged. The differences in the percentage current block produced by 3 microM drugs at 5 and 10 mmol/l [K(+)](e) were: -0.9% for amiodarone, 13.8% for quinidine, 20.5% for azimilide, and 16.2% for dofetilide. The differences in percentage block between 5 and 10 mmol/l [K(+)](e) by sotalol 10 and 30 mM were 7.1 and 5.6%. At 10 mmol/l [K(+)](e), the IC(50) was increased for azimilide, dofetilide, quinidine and sotalol but not for amiodarone; the IC(50) was 24.7 +/- 7.4 microM for amiodarone, 29.3 +/- 3.9 microM for azimilide, 2.7 +/- 0.2 microM for dofetilide, 27.6 +/- 4.0 microM for quinidine, and 7.2 +/- 1.7 mM for sotalol. CONCLUSION: Inhibition of IKr by azimilide, quinidine, dofetilide and sotalol was diminished by increasing [K(+)](e), while the inhibition by amiodarone was unchanged at normal and high [K(+)](e). The differential effects of azimilide, dofetilide, quinidine and sotalol at normal and high [K(+)](e) could be pro-arrhythmic by favoring re-entry arrhythmias. These results further support the unique electrophysiological effect of amiodarone.
机译:背景:高钾血症是一种潜在的威胁生命的疾病,经常发生在住院患者中。缺血性心肌将钾释放到细胞外空间,从而引起局部高钾血症。这些变化可能会改变抗心律失常药物对延迟整流钾电流(IKr)快速成分的作用。我们评估了增加的细胞外钾浓度[K(+)](e)对胺碘酮,阿齐米利,多非利特,奎尼丁和索他洛尔对IKr抑制的影响。方法与结果:实验在室温下进行。通过使用非洲爪蟾卵母细胞中表达的HERG基因作为心脏IKr模型研究IKr电流。采用两电极电压钳技术。记录浴溶液包含5或10 mmol / l KCl。胺碘酮,阿齐米利,多非利特,奎尼丁和索他洛尔均对HERG电流产生剂量依赖性抑制作用。在5 mmol / l [K(+)](e)时,胺碘酮的IC(50)为37.0 +/- 12.5 microM,阿齐米利为5.8 +/- 0.4 microM,多非利特为1.5 +/- 0. 2 microM,奎尼丁为9.1 +/- 1.5 mM,索他洛尔为5.1 +/- 0.8 mM。将细胞外钾增加至10 mmol / l,阿齐米利,多非利特,奎尼丁和索他洛尔对HERG的阻滞作用明显降低,而胺碘酮对HERG的阻滞作用未改变。 3种microM药物以5和10 mmol / l [K(+)](e)产生的电流阻断百分比的差异为:胺碘酮为-0.9%,奎尼丁为13.8%,阿齐米利为20.5%,而阿米立利为16.2%。多非利特。索他洛尔10和30 mM在5和10 mmol / l [K(+)](e)之间的百分比阻断百分比差异为7.1和5.6%。在10 mmol / l [K(+)](e)时,阿齐米利,多非利特,奎尼丁和索他洛尔的IC(50)增加,但胺碘酮则未增加;胺碘酮的IC(50)为24.7 +/- 7.4 microM,阿齐米利为29.3 +/- 3.9 microM,多芬替利为2.7 +/- 0.2 microM,奎尼丁为27.6 +/- 4.0 microM和7.2 +/- 1.7 mM索他洛尔。结论:通过增加[K(+)](e)可以降低阿齐米利,奎尼丁,多非利特和索他洛尔对IKr的抑制作用,而在正常和高[K(+)](e)情况下,胺碘酮的抑制作用均未改变。在正常和高[K(+)](e)时,阿齐米利,多非利特,奎尼丁和索他洛尔的差异作用可以通过促进再入性心律不齐而促进心律失常。这些结果进一步支持胺碘酮的独特电生理作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号